Inventor · disambiguated record
Mark Tengler
Also filed as: TENGLER MARK
16 granted patents·11 pending applications·254 citations·filing 2004–2023
94Inventor score
Top patents by PatentIndex Score
27 records- 0195US8709491B2Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particlesNEOS THERAPEUTICS LP·Filed 2013·Granted Apr 29, 2014·31 cites·9 claims
- 0294US9265737B2Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particlesNEOS THERAPEUTICS LP·Filed 2015·Granted Feb 23, 2016·15 cites·21 claims
- 0394US8840924B2Compositions and methods of making rapidly dissolving ionically masked formulationsTENGLER MARK·Filed 2010·Granted Sep 23, 2014·30 cites·25 claims
- 0493US8512759B1Methods of formulating and designing liquid drug suspensions containing ion exchange resin particlesMCMAHEN RUSSELL·Filed 2012·Granted Aug 20, 2013·18 cites·18 claims
- 0593US8470375B1Method of formulating and designing liquid drug suspensions containing ion exchange resin particlesMCMAHEN RUSSELL·Filed 2011·Granted Jun 25, 2013·25 cites·32 claims
- 0692US9089496B2Compositions comprising methylphenidate complexed with ion-exchange resin particlesNEOS THERAPEUTICS LP·Filed 2013·Granted Jul 28, 2015·15 cites·22 claims
- 0792US9072680B2Compositions comprising methylphenidate complexed with ion-exchange resin particlesNEOS THERAPEUTICS LP·Filed 2013·Granted Jul 7, 2015·15 cites·28 claims
- 0892US9057675B2Methods of formulating and designing liquid drug suspensions containing ion exchange resin particlesMCMAHEN RUSSELL·Filed 2013·Granted Jun 16, 2015·15 cites·23 claims
- 0992US9017731B2Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particlesTENGLER MARK·Filed 2013·Granted Apr 28, 2015·15 cites·20 claims
- 1091US8318210B2Compositions and methods of making sustained release liquid formulationsTENGLER MARK·Filed 2005·Granted Nov 27, 2012·51 cites·34 claims
- 1189US8313770B2Modifying drug release in suspensions of ionic resin systemsPATHAK YASHWANT VISHNUPANT·Filed 2008·Granted Nov 20, 2012·18 cites·28 claims
- 1283US10874741B2Compound to treat Sjogren's syndromeSPECTRIX THERAPEUTICS LLC·Filed 2018·Granted Dec 29, 2020·2 cites·8 claims
- 1381US9522120B2Compositions and methods of making sustained release liquid formulationsNEOS THERAPEUTICS LP·Filed 2013·Granted Dec 20, 2016·2 cites·19 claims
- 1468US11166947B2Effective dosing of a child for the treatment of ADHD with methylphenidateNEOS THERAPEUTICS LP·Filed 2017·Granted Nov 9, 2021·2 cites·2 claims
- 1563US11723979B2Compound to treat Sjogren's SyndromeSPECTRIX THERAPEUTICS LLC·Filed 2020·Granted Aug 15, 2023·0 cites·24 claims
- 1663US9839619B2Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particlesNEOS THERAPEUTICS LP·Filed 2013·Granted Dec 12, 2017·0 cites·37 claims
- 1761US2023285342A1Compositions and methodsSPECTRIX THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 1861US2015004240A1Compositions and methods of making rapidly dissolving ionically masked formulationsNEOS THERAPEUTICS LP·Filed 2014·Application pending·0 cites
- 1959US2013084340A1Compositions and Methods of Making Sustained Release Liquid FormulationsTENGLER MARK·Filed 2012·Application pending·0 cites
- 2057US2022362191A1Compositions and methodsSPECTRIX THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 2157US2007092553A1Compositions and methods of making rapidly dissolving lonically masked formulationsPFAB LP·Filed 2005·Application pending·0 cites
- 2256US2005152967A1Dynamic variable releasePFAB LP·Filed 2004·Application pending·0 cites
- 2356US2017281786A1Compositions and methods of making rapidly dissolving ionically masked formulationsNEOS THERAPEUTICS LP·Filed 2017·Application pending·0 cites
- 2448US2019133982A1Compositions and methods of providing thyroid hormone or analogs thereofSPECTRIX THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 2548US2014127300A1Abuse resistant drug formsNEOS THERAPEUTICS LP·Filed 2012·Application pending·0 cites
- 2644US2017319526A1Compositions and methods of providing thyroid hormone or analogs thereofSPECTRIX THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
- 2743US2018064669A1Compositions and methods of providing thyroid hormone or analogs thereofSPECTRIX THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Tengler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →